# Safety Study of BMS-844421 for Treatment of Hypercholesterolemia

> **NCT01082562** · PHASE1 · TERMINATED · sponsor: **Bristol-Myers Squibb** · enrollment: 40 (actual)

## Conditions studied

- Atherosclerosis
- Hypercholesterolemia

## Interventions

- **DRUG:** BMS-844421
- **DRUG:** 0.9% sodium chloride injection solution

## Key facts

- **NCT ID:** NCT01082562
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-04
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2011-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01082562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01082562, "Safety Study of BMS-844421 for Treatment of Hypercholesterolemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01082562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*